Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Joost J. van den Oord"'
Autor:
Vivien Marasigan, Canan Güvenç, Joost J. van den Oord, Marguerite Stas, Veerle Boecxstaens, Oliver Bechter, Pascal Wolter, Diether Lambrechts, Marjan Garmyn
Publikováno v:
Acta Dermato-Venereologica, Vol 99, Iss 12, Pp 1154-1159 (2019)
The rising incidence of cutaneous melanoma and its stable high mortality rates despite innovative cancer care, require better prediction of the clinical outcome. In a large cutaneous melanoma population we explored whether the known clinical risk fac
Externí odkaz:
https://doaj.org/article/791f416fecdf41659f1b07bba49a132c
Autor:
Jasper Wouters, Miguel Vizoso, Anna Martinez-Cardus, F. Javier Carmona, Olivier Govaere, Teresa Laguna, Jesuchristopher Joseph, Peter Dynoodt, Claudia Aura, Mona Foth, Roy Cloots, Karin van den Hurk, Balazs Balint, Ian G. Murphy, Enda W. McDermott, Kieran Sheahan, Karin Jirström, Bjorn Nodin, Girish Mallya-Udupi, Joost J. van den Oord, William M. Gallagher, Manel Esteller
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-16 (2017)
Abstract Background Cutaneous melanoma is the deadliest skin cancer, with an increasing incidence and mortality rate. Currently, staging of patients with primary melanoma is performed using histological biomarkers such as tumor thickness and ulcerati
Externí odkaz:
https://doaj.org/article/c8d582e4e15a4836ac917268c4fb77a8
Autor:
Asier Antoranz, Yannick Van Herck, Maddalena M. Bolognesi, Seodhna M. Lynch, Arman Rahman, William M. Gallagher, Veerle Boecxstaens, Jean-Christophe Marine, Giorgio Cattoretti, Joost J. van den Oord, Frederik De Smet, Oliver Bechter, Francesca M. Bosisio
Publikováno v:
Cancer Research. 82:3275-3290
While immune checkpoint–based immunotherapy (ICI) shows promising clinical results in patients with cancer, only a subset of patients responds favorably. Response to ICI is dictated by complex networks of cellular interactions between malignant and
Autor:
Geert Berx, Jean-Christophe Marine, Joost J. van den Oord, Steven Goossens, Pieter Van Vlierberghe, Florian Rambow, Vanessa Andries, Jody J. Haigh, Danny Huylebroeck, Lieve Brochez, William M. Gallagher, Balazs Balint, Mairin Rafferty, Udupi Girish Mallya, Mitchell P. Levesque, Marieke I.G. Raaijmakers, Phil F. Cheng, Douglas S. Darling, Corinna Köhler, David Nittner, Jasper Wouters, Wouter Van Loocke, Nicolas Skrypek, Eva De Smedt, Jordy De Coninck, Joachim Taminau, Özden Akay, Gillian Blancke, Kenneth Bruneel, Geertrui Denecker, Niels Vandamme
Epithelial-to-mesenchymal transition (EMT)-inducing transcription factors (TF) are well known for their ability to induce mesenchymal states associated with increased migratory and invasive properties. Unexpectedly, nuclear expression of the EMT-TF Z
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0dbb78cec573eb5d9cfa72896700558
https://doi.org/10.1158/0008-5472.c.6511625.v1
https://doi.org/10.1158/0008-5472.c.6511625.v1
Autor:
Francesca M. Bosisio, Oliver Bechter, Frederik De Smet, Joost J. van den Oord, Giorgio Cattoretti, Jean-Christophe Marine, Veerle Boecxstaens, William M. Gallagher, Arman Rahman, Seodhna M. Lynch, Maddalena M. Bolognesi, Yannick Van Herck, Asier Antoranz
Supplementary Data from Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell–Cell Interactions That Predict Immunotherapy Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f278c08a4fd8bea49dbb2bfeddb656f
https://doi.org/10.1158/0008-5472.22431972
https://doi.org/10.1158/0008-5472.22431972
Autor:
Francesca M. Bosisio, Oliver Bechter, Frederik De Smet, Joost J. van den Oord, Giorgio Cattoretti, Jean-Christophe Marine, Veerle Boecxstaens, William M. Gallagher, Arman Rahman, Seodhna M. Lynch, Maddalena M. Bolognesi, Yannick Van Herck, Asier Antoranz
Supplementary Table from Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell–Cell Interactions That Predict Immunotherapy Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06ebfe7743a0d34422f72966cd9de7b8
https://doi.org/10.1158/0008-5472.22431927
https://doi.org/10.1158/0008-5472.22431927
Autor:
Francesca M. Bosisio, Oliver Bechter, Frederik De Smet, Joost J. van den Oord, Giorgio Cattoretti, Jean-Christophe Marine, Veerle Boecxstaens, William M. Gallagher, Arman Rahman, Seodhna M. Lynch, Maddalena M. Bolognesi, Yannick Van Herck, Asier Antoranz
Supplementary Figure from Mapping the Immune Landscape in Metastatic Melanoma Reveals Localized Cell–Cell Interactions That Predict Immunotherapy Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106497a7395d06eafdeb7598110dd45b
https://doi.org/10.1158/0008-5472.22431963
https://doi.org/10.1158/0008-5472.22431963
Autor:
Francesca M. Bosisio, Oliver Bechter, Frederik De Smet, Joost J. van den Oord, Giorgio Cattoretti, Jean-Christophe Marine, Veerle Boecxstaens, William M. Gallagher, Arman Rahman, Seodhna M. Lynch, Maddalena M. Bolognesi, Yannick Van Herck, Asier Antoranz
While immune checkpoint–based immunotherapy (ICI) shows promising clinical results in patients with cancer, only a subset of patients responds favorably. Response to ICI is dictated by complex networks of cellular interactions between malignant and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b175d3222b780de77cf2426eebebc1ed
https://doi.org/10.1158/0008-5472.c.6514032.v1
https://doi.org/10.1158/0008-5472.c.6514032.v1
Autor:
Geert Berx, Jean-Christophe Marine, Joost J. van den Oord, Steven Goossens, Pieter Van Vlierberghe, Florian Rambow, Vanessa Andries, Jody J. Haigh, Danny Huylebroeck, Lieve Brochez, William M. Gallagher, Balazs Balint, Mairin Rafferty, Udupi Girish Mallya, Mitchell P. Levesque, Marieke I.G. Raaijmakers, Phil F. Cheng, Douglas S. Darling, Corinna Köhler, David Nittner, Jasper Wouters, Wouter Van Loocke, Nicolas Skrypek, Eva De Smedt, Jordy De Coninck, Joachim Taminau, Özden Akay, Gillian Blancke, Kenneth Bruneel, Geertrui Denecker, Niels Vandamme
Supplementary Figures. Supplementary Figure S1: Zeb2-wildtype cells outcompete Zeb2-negative cells in terms of expansion and differentiation. Supplementary Figure S2: Zeb2 does not accelerate melanoma development on a p53-wildtype background. Supplem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7334c2f0fa8adb45c9f55791cdcb1875
https://doi.org/10.1158/0008-5472.22423952
https://doi.org/10.1158/0008-5472.22423952
Autor:
Marc Ferrante, Maja Noman, Thomas Billiet, Vera Ballet, Pieter Vandecandelaere, Paul Rutgeerts, Ann Gils, Severine Vermeire, Joost J. van den Oord, Niels Vande Casteele, Christine Breynaert, Isabelle Cleynen, Wouter Van Moerkercke, Siegfried Segaert, Gert Van Assche
Publikováno v:
Annals of internal medicine. 164(1)
Background A subgroup of patients with inflammatory bowel disease (IBD) treated with anti-tumor necrosis factor (TNF) antibodies develop skin lesions, but the lesions and their clinical course are not well-characterized. Objective To describe patient